Selective Blockade of N‐Type Calcium Channels by Levetiracetam
Authors:
Abstract
Summary: Purpose: We investigated the effect of the new antiepileptic drug (AED) levetiracetam (LEV) on different types of high‐voltage–activated (HVA) Ca2+ channels in freshly isolated CA1 hippocampal neurons of rats.Methods: Patch‐clamp recordings of HVA Ca2+ channel activity were obtained from isolated hippocampal CA1 neurons. LEV was applied by gravity flow from a pipette placed near the cell, and solution changes were made by electromicrovalves. Ca2+ channel blockers were used for separation of the channel subtypes.Results: The currents were measured in controls and after application of 1–200 μM LEV. LEV irreversibly inhibited the HVA calcium current by ∼18% on the average. With a prepulse stimulation protocol, which can eliminate direct inhibition of Ca2+ channels by G proteins, we found that G proteins were not involved in the pathways underlying the LEV inhibitory effect. This suggested that the inhibitory effect arises from a direct action of LEV on the channel molecule. The blocking mechanism of LEV was not related to changes in steady‐state activation or inactivation of Ca2+ channels. LEV also did not influence the rundown of the HVA Ca2+ current during experimental protocols lasting ∼10 min. Finally, LEV at the highest concentration used (200 μM) did not influence the activity of L‐, P‐ or Q‐type Ca2+ channels in CA1 neurons, while selectively influencing the activity of N‐type calcium channels. The maximal effect on these channels separated from other channel types was ∼37%.Conclusions: Our results provide evidence that LEV selectively inhibits N‐type Ca2+ channels of CA1 pyramidal hippocampal neurons. These data suggest the existence of a subtype of N‐type channels sensitive to LEV, which might be involved in the molecular basis of its antiepileptic action.Keywords
This publication has 52 references indexed in Scilit:
- LevetiracetamDrugs, 2000
- Structure-activity relationships of ?-conotoxins at N-type voltage-sensitive calcium channelsJournal of Molecular Recognition, 2000
- Treatment of epilepsy in the multiply handicappedMental Retardation and Developmental Disabilities Research Reviews, 2000
- Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatumBritish Journal of Pharmacology, 1999
- Structure-Activity Analysis of a Conus Peptide Blocker of N-Type Neuronal Calcium ChannelsBiochemistry, 1995
- Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxinNature, 1994
- CALCIUM CHANNEL DIVERSITY AND NEUROTRANSMITTER RELEASE: The ω-Conotoxins and ω-AgatoxinsAnnual Review of Biochemistry, 1994
- Distinctive biophysical and pharmacological properties of class A (BI) calcium channel α1 subunitsNeuron, 1993
- Omega Conus geographus toxin: A peptide that blocks calcium channelsFEBS Letters, 1987
- Binding of ω-conotoxin to receptor sites associated with the voltage-sensitive calcium channelNeuroscience Letters, 1986